Advertisement
U.S. markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
14.10-0.33 (-2.25%)
At close: 03:59PM EDT
14.05 -0.05 (-0.39%)
After hours: 04:10PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close14.43
Open14.35
Bid14.12 x 4000
Ask14.13 x 3100
Day's Range13.97 - 14.41
52 Week Range7.09 - 14.45
Volume9,498,551
Avg. Volume11,008,891
Market Cap15.812B
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
14% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TEVA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Teva Pharmaceutical Industries
    Analyst Report: Teva Phar Inds LtTeva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has roughly 37,000 employees and over 53 manufacturing facilities across more than 33 countries. One of every 12 prescriptions in the U.S. is filled with Teva products.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more